Marc J. Blazer This is Me

Education

 View all 29 references Web References

1. 1. Cantor.com - Cantor Fitzgerald And Co. Investment Banking Group Expands with Hiring of Technology Banking Team - Cantor Fitzgerald

   www.cantor.com/press_releases/ - [Cached]

   Published on: 8/2/2006   Last Visited: 3/22/2008

   The Technology Banking Team will be based in the San Francisco Bay Area, and report to Marc Blazer, Global Head of Investment Banking at Cantor Fitzgerald.
   ...
   "We are pleased to hire such an experienced and accomplished technology team," said Marc Blazer, Global Head of Investment Banking at Cantor Fitzgerald.

2. 2. TelecomWeb

   www.telecomweb.com/pressreleas - [Cached]

   Published on: 5/4/2002   Last Visited: 5/4/2002

   * Marc Blazer, managing director, Cantor Fitzgerald Investment Banking

3. 3. NeoTherapeutics Retains Cantor Fitzgerald & Co.

   www.neotherapeutics.com/pr/r01 - [Cached]

   Published on: 7/12/2001   Last Visited: 12/8/2002

   When available, copies of the prospectus relating to the offering may be obtained from Marc Blazer, Managing Director at Cantor Fitzgerald & Co., One World Trade Center, 104th Floor, New York, NY 10048.
   
   NeoTherapeutics is a research pharmaceutical company engaged in the development of central nervous system drugs through its neurology division, in-licensing and development of anti-cancer drugs through its NeoOncoRx subsidiary, and the licensing out of new drug targets through its NeoGene Technologies subsidiary. NeoTherapeutics' most advanced drug, Neotrofin, is currently being developed for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease and spinal cord injury. For additional information visit the Company's web site at www.neotherapeutics.com.
   
   This press release may contain forward-looking statements regarding future events and the future performance of NeoTherapeutics that involve risks and uncertainties that could cause actual results to differ materially. These risks are described in further detail in the Company's reports filed with the Securities and Exchange Commission.